Sue Yom

Sue S. Yom, M.D., Ph.D.

Departments of Radiation Oncology &
Otolaryngology-Head and Neck Surgery

University of California, San Francisco
Helen Diller Family Comprehensive Cancer Center
Box 1708, 1600 Divisadero St,  H1031
San Francisco, CA 94115
Phone: 415-353-9893
Fax: 415-353-9883
Email: sue.yom[at]

Make A Gift Button

Professional Focus

Dr. Yom is a radiation oncologist who specializes in the treatment of head and neck, skin and thoracic cancers. She is particularly interested in understanding biologic processes which have impact on the efficacy of radiation therapy, as well as emerging radiotherapeutic, biologic, and clinical techniques aimed at reducing the toxicities of treatment. In head and neck and skin cancer, she has studied a variety of issues related to chemoradiation and combined modality treatments, technical aspects of radiation delivery, and radiation-related prognostic factors and post-treatment management. In lung cancer, she has conducted research on combined modality treatment and is experienced in both stereotactic and intensity-modulated radiation techniques in the treatment of early-stage and locoregionally advanced lung cancers. She is experienced with many rare tumor types in the head and neck, cutaneous, and thoracic regions.

Dr. Yom is a national-level investigator in the NRG Oncology cancer research group. At UCSF, she supervises a number of translational biologically and radiographically based studies as well as clinical trials aimed at finding novel and more effective forms of therapy. She is a member of several national-level guidelines committees issuing recommended pathways for high quality cancer care. She regularly participates in major educational conferences and works as an editor or reviewer at several cancer journals.

Dr. Yom is committed to UCSF’s tradition of technical innovation and provides consultation for her patients drawing from a wide range of radiotherapy techniques, to produce the best individualized plan for each patient. It is hoped that the continuous optimization of radiotherapy practice and the reduction of toxicities, both through technical and biologic means, will improve quality of life and enable physicians to deliver more intelligently targeted treatments in search of a better chance of cure. She believes in multidisciplinary management and a unified, team-oriented approach to patient care.


1987-1991 Rice University BA French
1993-2003 University of Pennsylvania Ph.D. English
1995-2002 University of Pennsylvania M.D. Medicine
2002-2003 MD Anderson Cancer Center Intern Medicine/Surgery
2003-2007 MD Anderson Cancer Center Resident Radiation Oncology

Professional Experience

2007-2013 UCSF
Assistant Professor
Radiation Oncology
2007-present SF VAMC
2009-2013 UCSF
Assistant Professor
Otolaryngology-Head and Neck Surgery
2013-2018 UCSF
Associate Professor
Otolaryngology-Head and Neck Surgery
2013-2018 UCSF Associate Professor Radiation Oncology
2018-present UCSF Professor Radiation Oncology
2018-present UCSF Professor Otolaryngology-Head and Neck Surgery 

Organizational Service

2009-2010 International Association for the Study of Lung Cancer (IASLC), Abstract Review Committee of the International Scientific Committee, Abstract Reviewer - Radiotherapy Track
2009-2011 American College of Radiology (ACR), Appropriateness Criteria Expert Panel on Radiation Oncology - Head and Neck, Member
2009-2013 Radiation Therapy Oncology Group (RTOG), Health Services Research & Outcomes Committee, Member
2011-2013 American Radium Society (ARS), Executive Committee, Member at Large
2010-2012 American Radium Society (ARS), Educational Resources Committee, Member
2011-Present Journal of Radiation Oncology, Editorial Board, Member
2011-Present American Radium Society (ARS), Scientific Program Committee, Abstract Reviewer
2011-Present American Society for Radiation Oncology (ASTRO), Annual Meeting Scientific Committee, Abstract Reviewer - Head and Neck
2011-Present CME/MOC Committee of the Education Council, Member
2013-Present American College of Radiology (ACR), Appropriateness Criteria Expert Panel on Radiation Oncology - Head and Neck, Panel Chair
2011-Present American Board of Radiology (ABR), Maintenance of Certification Advisory Committee, Member
2012-Present American Board of Radiology (ABR), Testing Category Committee, Category 08 - Lung/ Mediastinum/Sarcoma (develop national specialty board written and oral exams), Member
2012-Present National Cancer Institute/National Institutes of Health, Lung Cancer Clinical Trials Working Group, Member

National Comprehensive Cancer Network, Head and Neck Cancers Panel, Member

2013-Present American College of Radiology (ACR), Appropriateness Criteria Methodology Committee, Member
2013-2015 International Journal of Radiation Oncology, Biology, and Physics, Senior Editor (Head and Neck Cancers)
2014 - present NRG Oncology (formerly RTOG), Patient-Centered Outcomes Research (PCOR) Committee, Member
2014 - present NRG Oncology (formerly RTOG), Head and Neck Cancer Committee, Member
2014 - present NRG Oncology (formerly RTOG), Publications Committee, Member

Awards & Honors

1992 Andrew W. Mellon Fellow in the Humanities, National Mellon Foundation
1995 Benjamin Franklin Medical Scholar Fellowship, University of Pennsylvania
2001 Seed Grant Research Program, American Medical Association Foundation
2004 Biostatistics and Trial Design Workshop, Cancer Education Consortium
2005 International Travel Grant, Women Against Lung Cancer (now National Lung Cancer Partnership)
2005 ASTRO Fellowship, Korean American Society for Therapeutic Radiology & Oncology
2006 Jesse H. Jones Fellowship in Cancer Education, for excellence in cancer education at M.D. Anderson Cancer Center
2006 A. Lavoy Moore Endowment Fund, for excellence in lung cancer research at M.D. Anderson Cancer Center
2006 Travel Award, Radiation Therapy Oncology Group
2006 Eleanor Montague Distinguished Resident Award in Radiation Oncology, American Association of Women Radiologists
2006 Travel Award, ASTRO Health Services/Outcomes Symposium
2006 Brachytherapy Fellowship, American Brachytherapy Society
2007 LORHAN Fellows Travel Grant, ASTRO Multidisciplinary Head and Neck Symposium
2007 ASCO/AACR Workshop on Methods in Clinical Cancer Research
2008 Joan F. Giambalvo Memorial Scholarship, AMA Women Physicians Congress
2009 Best Doctors in America ®
2010 Pilot Research Award for Junior Investigator, Research Allocation Program
2011 Marquis Who's Who in the World
2011 Best Doctors in America ®
2011 Faculty Educational Research Grant, Office of Medical Education Educational Research Program
2013 Selected for biannual listing, Best Doctors in America 2013-2014
2013 Young Investigator Award, National Comprehensive Cancer Network Foundation
2014 Listed in Marquis Who's Who in America, 68th ed.


Recent Significant Publications :

Salama JK, Golden DW, Yom SS, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Smith RV, Worden F, Yeung AR, Beitler JJ. ACR Appropriateness Criteria® Thyroid Carcinoma. Oral Oncology 2014;50(6):577-86. doi: 10.1016/j.oraloncology.2013.12.004. PubMed PMID: 24824115.

Yu J, Aldabagh B, Wang J, Yom SS, El-Sayed I, Knott D, McGrath MH, Arron S. Multidisciplinary Management of Advanced Basal Cell Carcinoma: Report of Four Cases. Journal of Drugs in Dermatology 2014;13(5):601-606.

Braunstein SE, Dionisio SA, Lometti MW, Pinnaduwage DS, Chuang CF, Yom SS, Gottschalk AR, Descovich M. Evaluation of Ray Tracing and Monte Carlo Algorithms in Dose Calculation and Clinical Outcomes for Robotic Stereotactic Body Radiotherapy of Lung Cancers. Journal of Radiosurgery and SBRT 2014; 3(1):67-79.

Chainani-Wu N, Chang C, Gross A, Yom SS, Silverman S. Oropharyngeal Carcinoma Arising After Methotrexate and Etanercept Therapy for Rheumatoid Arthritis.. Medicine, Oral Pathology, Oral Radiology and Endodontology 2014 Mar;117(3):e261-3. doi: 10.1016/j.oooo.2013.11.499. Epub 2013 Dec 7.

Ouyang D, El-Sayed IH, Yom SS. National Trends in Surgery for Sinonasal Malignancy and the Effect of Hospital Volume on Short Term Outcomes. Laryngoscope 2014 Jan 4. doi: 10.1002/lary.24578. [Epub ahead of print]

Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, McGuinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom SS. Analysis of Dose Distribution and Risk of Pneumonitis in Stereotactic Body Radiation Therapy for Centrally Located Lung Tumors: A Comparison of Robotic Radiosurgery, Helical Tomotherapy and Volumetric Modulated Arc Therapy. Technology in Cancer Research and Treatment 2013 Nov 6. [Epub ahead of print]

George JR, Yom SS, Wang SJ. Improved outcomes for oral cavity carcinoma adjuvant radiotherapy at an academic center: matched-pair analysis.. Laryngoscope 2013 Dec 7. doi: 10.1002/lary.24552. [Epub ahead of print].

George JR, Yom SS, Wang SJ. Combined Modality Treatment Outcomes for Head and Neck Cancer: Comparison of Postoperative Radiation Therapy at Academic vs Nonacademic Medical Centers. JAMA Otolaryngology Head and Neck Surgery 2013. doi:10.1001/jamaoto.2013.4539 Nov 1;139(11):1118-26.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M.Head and Neck Cancers, Version 2.2013. Journal of the National Comprehensive Cancer Network 2013 Aug 1;11(8):917-923.

Ridge JA, Lawson J, Yom SS, Garg MK, McDonald MW, Quon H, Saba N, Salama JK, Smith RV, Worden F, Yeung AR, Beitler JJ. ACR Appropriateness Criteria® Treatment of Stage 1 T1 Glottic Cancer.. Head Neck. 2013 May 21. doi: 10.1002/hed.23381. [Epub ahead of print]

Garg MK, Ridge JA, Yom SS, McDonald MW, Quon H, Smith RV, Yeung AR, Lawson J, Saba N, Salama JK, Beitler JJ. Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer. Head Neck. 2013 Mar;35(3):465-6.

Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS. Divergent Management Strategies for Typical Versus Atypical Carcinoid Tumors of the Thoracic Cavity. Am J Clin Oncol. 2013 Jan 24.